NORGESTIMATE, E-

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C23H31NO3
Molecular Weight	369.4971
Optical Activity	UNSPECIFIED
Defined Stereocenters	6 / 6
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]3([H])[C@@]4([H])CC\C(C=C4CC[C@@]23[H])=N/O

InChI

InChIKey=KIQQMECNKUGGKA-NMYWJIRASA-N

InChI=1S/C23H31NO3/c1-4-22-12-10-19-18-9-7-17(24-26)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)27-15(3)25/h2,14,18-21,26H,4,6-13H2,1,3H3/b24-17+/t18-,19+,20+,21-,22-,23-/m0/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

NORGESTIMATE, E-

Common Name

English

18,19-DINORPREGN-4-EN-20-YN-3-ONE, 17-(ACETYLOXY)-13-ETHYL-, 3-OXIME, (3E,17.ALPHA.)-

Systematic Name

English

ANTI-NORGESTIMATE

Common Name

English

Code System Code Type Description

PUBCHEM

6540478

Created by admin on Sat Dec 16 16:56:45 GMT 2023 , Edited by admin on Sat Dec 16 16:56:45 GMT 2023

PRIMARY

FDA UNII

NKX8DN6TY9

Created by admin on Sat Dec 16 16:56:45 GMT 2023 , Edited by admin on Sat Dec 16 16:56:45 GMT 2023

PRIMARY

CAS

107382-52-5

Created by admin on Sat Dec 16 16:56:45 GMT 2023 , Edited by admin on Sat Dec 16 16:56:45 GMT 2023

PRIMARY

SUBSTANCE RECORD


					NKX8DN6TY9

NORGESTIMATE, E-